Medy-Tox Inc. (KOSDAQ:086900)
South Korea
· Delayed Price · Currency is KRW 162,900
-2,500 (-1.51%)
Jun 27, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Biopharmaceutical Products | 217.16B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biopharmaceutical Products Growth | 13.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Other | 226.72M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea | 79.82B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea Growth | 19.66% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia | 73.71B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Growth | 6.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
America | 48.30B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
America Growth | 10.69% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Middle East | 8.54B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Middle East Growth | 73.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 6.56B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | 0.15% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 226.72M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Africa | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Africa Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Oceania | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Oceania Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|